Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Avantor

NYSE:AVTR
Snowflake Description

Moderate growth potential with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
AVTR
NYSE
$7B
Market Cap
  1. Home
  2. US
  3. Pharmaceuticals & Biotech
Company description

Avantor, Inc. manufactures, distributes, and sells products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries in the Americas, Europe, Asia, the Middle-East, and Africa. The last earnings update was 55 days ago. More info.


Add to Portfolio Compare Print
  • Avantor has significant price volatility in the past 3 months.
AVTR Share Price and Events
7 Day Returns
5.9%
NYSE:AVTR
7.3%
US Life Sciences
8%
US Market
1 Year Returns
-
NYSE:AVTR
-1.2%
US Life Sciences
-8.1%
US Market
AVTR Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Avantor (AVTR) 5.9% -5.4% -28.1% - - -
US Life Sciences 7.3% -0.4% -12.1% -1.2% 72.6% 92.9%
US Market 8% -4.5% -17.8% -8.1% 13.2% 23.7%
1 Year Return vs Industry and Market
  • No trading data on AVTR.
  • No trading data on AVTR.
Price Volatility
Industry
5yr Volatility vs Market
Related Companies

AVTR Value

 Is Avantor undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Avantor to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Avantor.

NYSE:AVTR Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 15 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.7%
Perpetual Growth Rate 10-Year US Government Bond Rate 1.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NYSE:AVTR
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 1.7%
Equity Risk Premium S&P Global 5.4%
Life Sciences Unlevered Beta Simply Wall St/ S&P Global 0.92
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.918 (1 + (1- 21%) (70.09%))
1.286
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.29
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.74% + (1.286 * 5.44%)
8.74%

Discounted Cash Flow Calculation for NYSE:AVTR using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Avantor is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

NYSE:AVTR DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 8.74%)
2020 463.31 Analyst x9 426.09
2021 591.60 Analyst x8 500.36
2022 678.06 Analyst x5 527.41
2023 602.00 Analyst x1 430.63
2024 633.00 Analyst x1 416.43
2025 639.71 Est @ 1.06% 387.03
2026 647.80 Est @ 1.26% 360.44
2027 656.91 Est @ 1.41% 336.14
2028 666.81 Est @ 1.51% 313.80
2029 677.32 Est @ 1.58% 293.14
Present value of next 10 years cash flows $3,991.00
NYSE:AVTR DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $677.32 × (1 + 1.74%) ÷ (8.74% – 1.74%)
$9,850.26
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $9,850.26 ÷ (1 + 8.74%)10
$4,263.06
NYSE:AVTR Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $3,991.00 + $4,263.06
$8,254.06
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $8,254.06 / 572.91
$14.41
NYSE:AVTR Discount to Share Price
Calculation Result
Value per share (USD) From above. $14.41
Current discount Discount to share price of $13.09
= -1 x ($13.09 - $14.41) / $14.41
9.1%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Avantor is available for.
Intrinsic value
9%
Share price is $13.09 vs Future cash flow value of $14.41
Current Discount Checks
For Avantor to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Avantor's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • Avantor's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Avantor's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Avantor's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NYSE:AVTR PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $-0.84
NYSE:AVTR Share Price ** NYSE (2020-04-08) in USD $13.09
United States of America Life Sciences Industry PE Ratio Median Figure of 19 Publicly-Listed Life Sciences Companies 32.37x
United States of America Market PE Ratio Median Figure of 2,949 Publicly-Listed Companies 13.31x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Avantor.

NYSE:AVTR PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:AVTR Share Price ÷ EPS (both in USD)

= 13.09 ÷ -0.84

-15.67x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Avantor is loss making, we can't compare its value to the US Life Sciences industry average.
  • Avantor is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Avantor's expected growth come at a high price?
Raw Data
NYSE:AVTR PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -15.67x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 15 Analysts
79.6%per year
United States of America Life Sciences Industry PEG Ratio Median Figure of 16 Publicly-Listed Life Sciences Companies 2.3x
United States of America Market PEG Ratio Median Figure of 2,009 Publicly-Listed Companies 0.9x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Avantor, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Avantor's assets?
Raw Data
NYSE:AVTR PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $2.55
NYSE:AVTR Share Price * NYSE (2020-04-08) in USD $13.09
United States of America Life Sciences Industry PB Ratio Median Figure of 38 Publicly-Listed Life Sciences Companies 4.66x
United States of America Market PB Ratio Median Figure of 5,163 Publicly-Listed Companies 1.29x
NYSE:AVTR PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:AVTR Share Price ÷ Book Value per Share (both in USD)

= 13.09 ÷ 2.55

5.14x

* Primary Listing of Avantor.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Avantor is overvalued based on assets compared to the US Life Sciences industry average.
X
Value checks
We assess Avantor's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Life Sciences industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Life Sciences industry average (and greater than 0)? (1 check)
  5. Avantor has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

AVTR Future Performance

 How is Avantor expected to perform in the next 1 to 3 years based on estimates from 15 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
79.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Avantor expected to grow at an attractive rate?
  • Avantor's earnings growth is expected to exceed the low risk savings rate of 1.7%.
Growth vs Market Checks
  • Avantor's earnings growth is expected to exceed the United States of America market average.
  • Avantor's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NYSE:AVTR Future Growth Rates Data Sources
Data Point Source Value (per year)
NYSE:AVTR Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 15 Analysts 79.6%
NYSE:AVTR Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 15 Analysts 3.2%
United States of America Life Sciences Industry Earnings Growth Rate Market Cap Weighted Average 17.6%
United States of America Life Sciences Industry Revenue Growth Rate Market Cap Weighted Average 6.4%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 6.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NYSE:AVTR Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 15 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NYSE:AVTR Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2024-12-31 6,703 1
2023-12-31 6,395 1
2022-12-31 6,779 823 427 8
2021-12-31 6,477 674 339 15
2020-12-31 6,146 537 240 15
2020-04-09
NYSE:AVTR Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 6,040 354 -335
2019-09-30 5,990 337 -514
2019-06-30 5,981 247 -554
2019-03-31 5,926 229 -330
2018-12-31 5,864 201 -356
2018-09-30 5,120 -16 -640
2017-12-31 1,247 -168 -415

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Avantor's earnings are expected to grow significantly at over 20% yearly.
  • Avantor's revenue is expected to grow by 3.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NYSE:AVTR Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 15 Analyst Estimates (S&P Global) See Below

All data from Avantor Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:AVTR Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2024-12-31
2023-12-31
2022-12-31
2021-12-31
2020-12-31 0.40 0.40 0.40 1.00
2020-04-09
NYSE:AVTR Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 -0.84
2019-09-30 -1.77
2019-06-30 -3.07
2019-03-31 -2.49
2018-12-31 -2.69
2018-09-30 -4.72
2017-12-31 -2.75

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Avantor is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Avantor's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Avantor has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

AVTR Past Performance

  How has Avantor performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Avantor's growth in the last year to its industry (Life Sciences).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Avantor does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Avantor's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Avantor's 1-year growth to the US Life Sciences industry average as it is not currently profitable.
Earnings and Revenue History
Avantor's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Avantor Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:AVTR Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 6,040.30 -335.10 1,339.50
2019-09-30 5,990.20 -514.00 1,319.20
2019-06-30 5,980.60 -554.10 1,332.00
2019-03-31 5,926.10 -329.90 1,305.30
2018-12-31 5,864.30 -356.40 1,319.20
2018-09-30 5,120.10 -639.50 1,214.80
2017-12-31 1,247.40 -414.90 376.00
2016-12-31 691.30 -42.40 256.50
2015-12-31 636.90 21.60 185.20

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Avantor has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Avantor used its assets less efficiently than the US Life Sciences industry average last year based on Return on Assets.
  • It is difficult to establish if Avantor improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Avantor's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Life Sciences industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Avantor has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

AVTR Health

 How is Avantor's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Avantor's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Avantor is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Avantor's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Avantor's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Avantor Company Filings, last reported 3 months ago.

NYSE:AVTR Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 2,462.20 5,057.30 186.70
2019-09-30 2,355.60 5,070.40 173.90
2019-06-30 2,410.90 5,260.70 164.60
2019-03-31 792.70 6,731.60 143.90
2018-12-31 807.60 6,858.40 184.70
2018-09-30 891.60 6,995.10 171.80
2017-12-31 969.60 7,117.80 185.40
2016-12-31 -510.60 1,296.10 62.90
2015-12-31
  • Avantor's level of debt (205.4%) compared to net worth is high (greater than 40%).
  • Unable to establish if Avantor's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Avantor has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Avantor has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -37.1% per year.
X
Financial health checks
We assess Avantor's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Avantor has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

AVTR Dividends

 What is Avantor's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Avantor dividends. Estimated to be 0% next year.
If you bought $2,000 of Avantor shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Avantor's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Avantor's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NYSE:AVTR Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 15 Analyst Estimates (S&P Global) See Below
United States of America Life Sciences Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 0.4%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1933 Stocks 2.8%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.9%
United States of America Top 25% Dividend Yield 75th Percentile 5.3%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NYSE:AVTR Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2024-12-31
2023-12-31
2022-12-31 0.00 2.00
2021-12-31 0.00 4.00
2020-12-31 0.00 4.00
2020-04-09

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Avantor has not reported any payouts.
  • Unable to verify if Avantor's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Avantor's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Avantor has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Avantor's dividends in 3 years as they are not expected to pay a notable one for United States of America.
X
Income/ dividend checks
We assess Avantor's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Avantor afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Avantor has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

AVTR Management

 What is the CEO of Avantor's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Michael Stubblefield
COMPENSATION $2,722,311
AGE 47
TENURE AS CEO 6.3 years
CEO Bio

Mr. Michael Stubblefield has been the Chief Executive Officer of Avantor Performance Materials, Inc. since May 2014. Mr. Stubblefield he been President and Chief Executive Officer of Avantor, Inc. since 2014. Mr. Stubblefield has more than 20 years of global chemical industry leadership experience. Mr. Stubblefield served as a senior expert for the Chemicals Practice of McKinsey & Company. He served as General Manager of Ticona Gmbh since November 2010. Mr. Stubblefield served as the Chief Marketing Officer of Celanese Corp. from November 2009 to November 2010. He has long tenure with Celanese, a global technology and specialty materials company. At Celanese, Mr. Stubblefield held various global leadership positions over the years, including vice president and general manager - advanced engineered materials, vice president and general manager - EVA performance polymers, global supply chain director - acetyl intermediates and Asia commercial director - emulsion polymers. He holds an MBA from Texas A&M University-Corpus Christi and a Bachelor of Science degree in chemical engineering from the University of Utah.

CEO Compensation
  • Insufficient data for Michael to compare compensation growth.
  • Michael's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Avantor management team in years:

1.6
Average Tenure
52
Average Age
  • The average tenure for the Avantor management team is less than 2 years, this suggests a new team.
Management Team

Michael Stubblefield

TITLE
President
COMPENSATION
$3M
AGE
47
TENURE
6.3 yrs

Tom Szlosek

TITLE
Executive VP & CFO
COMPENSATION
$7M
AGE
55
TENURE
1.3 yrs

Ger Brophy

TITLE
Executive Vice President of Biopharma Production
COMPENSATION
$4M
AGE
53
TENURE
1.8 yrs

Frederic Vanderhaegen

TITLE
Executive Vice President of Europe
COMPENSATION
$3M
AGE
52
TENURE
1.5 yrs

Steven Eck

TITLE
Senior VP & Chief Accounting Officer
AGE
43
TENURE
0.9 yrs

Michael Wondrasch

TITLE
Executive VP & Chief Information Officer
AGE
50
TENURE
2 yrs

Tommy Thomas

TITLE
Vice President of Investor Relations
TENURE
0.1 yrs

Joseph Braun

TITLE
Chief Legal Officer

Robert Donohoe

TITLE
Senior Director of Corporate Communications

Eric McAllister

TITLE
Executive VP & Chief Human Resources Officer
AGE
54
TENURE
3.1 yrs
Board of Directors Tenure

Average tenure and age of the Avantor board of directors in years:

2.4
Average Tenure
53
Average Age
  • The average tenure for the Avantor board of directors is less than 3 years, this suggests a new board.
Board of Directors

Raj Gupta

TITLE
Chairman
COMPENSATION
$547K
AGE
74
TENURE
10.3 yrs

Michael Stubblefield

TITLE
President
COMPENSATION
$3M
AGE
47

Matt Holt

TITLE
Director
AGE
42
TENURE
10.3 yrs

Jon Peacock

TITLE
Director
COMPENSATION
$840K
AGE
61
TENURE
3.3 yrs

Tom Connolly

TITLE
Director
AGE
61
TENURE
2.4 yrs

Andre Moura

TITLE
Director
AGE
37
TENURE
5.3 yrs

Jo Natauri

TITLE
Director
AGE
41
TENURE
1.4 yrs

Christi Shaw

TITLE
Director
COMPENSATION
$797K
AGE
52
TENURE
1.4 yrs

Rakesh Sachdev

TITLE
Director
AGE
63
TENURE
1 yrs

Juan Andres

TITLE
Independent Director
AGE
54
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
23. May 19 Sell New Mountain Capital, L.L.C Company 21. May 19 21. May 19 -100 $14.00 $-1,400
X
Management checks
We assess Avantor's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Avantor has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

AVTR News

Simply Wall St News

Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)

Today, we will estimate the stock's intrinsic value by projecting its future cash flows and then discounting them to today's value. … Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 10-year free cash flow (FCF) forecast 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 Levered FCF ($, Millions) $525.4m $669.4m $669.0m $740.5m $797.9m $847.8m $891.8m $931.6m $968.2m $1.0b Growth Rate Estimate Source Analyst x14 Analyst x12 Analyst x2 Analyst x2 Est @ 7.76% Est @ 6.25% Est @ 5.19% Est @ 4.45% Est @ 3.94% Est @ 3.58% Present Value ($, Millions) Discounted @ 10.58% $475.1 $547.4 $494.8 $495.3 $482.6 $463.7 $441.1 $416.7 $391.7 $366.9 ("Est" = FCF growth rate estimated by Simply Wall St) Present Value of 10-year Cash Flow (PVCF)= $4.6b We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. … In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 10.6%.

Simply Wall St -

AVTR Company Info

Description

Avantor, Inc. manufactures, distributes, and sells products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries in the Americas, Europe, Asia, the Middle-East, and Africa. The company’s materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, and process chromatography resins and columns, as well as analytical sample prep, education, and microbiology and clinical trial kits. Its equipment and instrumentation products comprise filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and environment supplies. The company also provides onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Details
Name: Avantor, Inc.
AVTR
Exchange: NYSE
Founded: 1904
$7,499,331,568
572,905,391
Website: http://www.avantorsciences.com
Address: Avantor, Inc.
Radnor Corporate Center,
Building One,
Radnor,
Pennsylvania, 19087,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE AVTR Common Stock New York Stock Exchange US USD 17. May 2019
DB AVG Common Stock Deutsche Boerse AG DE EUR 17. May 2019
BST AVG Common Stock Boerse-Stuttgart DE EUR 17. May 2019
WBAG AVTR Common Stock Wiener Boerse AG AT EUR 17. May 2019
XNYS AVTR Common Stock New York Stock Exchange, Inc. Floor US USD 17. May 2019
NYSE AVTR.PRA 6.25 PFD CNV SR New York Stock Exchange US USD 17. May 2019
Number of employees
Current staff
Staff numbers
12,000
Avantor employees.
Industry
Life Sciences Tools and Services
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/09 03:36
End of day share price update: 2020/04/08 00:00
Last estimates confirmation: 2020/04/07
Last earnings filing: 2020/02/14
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.